US 8580844
Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
granted A61KA61K2039/55511A61K31/343
Quick answer
US patent 8580844 (Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities) held by Georgia Regents Research Institute, Inc. expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Georgia Regents Research Institute, Inc.
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/55511, A61K31/343, A61K31/381, A61K31/405